HOME >> BIOLOGY >> NEWS
Protein targets tumor vasculature, delays tumor growth in animal study

Treatment with a protein fused to an antibody in tumor-bearing mice led to coagulation of the blood within the tumor blood vessels, tumor tissue death, and tumor growth delay, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.

The tumor vasculature has become an attractive target in the treatment of cancer. The U.S. Food and Drug Administration approved the first antiangiogenic cancer drug, bevacizumab (Avastin), last year, and other drugs in this category are under development. One approach in the design of these treatments is to develop molecules that effectively induce coagulation in the tumor vasculature when delivered systemically (i.e., intravenously) but that do not induce coagulation in nontumor vessels.

Claudia Gottstein, M.D., of the University Hospital Cologne in Germany, and colleagues created fusion proteins consisting of soluble tissue factor (sTF) genetically fused to antibody fragments directed against mouse or human vascular cell adhesion molecule 1 (VCAM-1), an antigen found on the inner surface of tumor blood vessels, which is the first site within the body that is exposed to intravenous drugs. They examined the activity of the proteins in laboratory studies and tested their antitumor effects when administered systemically to mouse models of human Hodgkin lymphoma and small-cell lung carcinoma and a mouse model of small-cell lung carcinoma that contained human tumor vasculature.

A single systemic administration of the fusion protein led to tumor tissue death. Long-term treatment produced delays in tumor growth and some tumor regressions. The researchers could find no evidence for the development of blood clots or cellular death in normal tissues related to the treatment.

The authors note that this research is one step beyond vascular occluding drugs, which have been effective in clinical studies when applied locally but that could not be administered intravenously be
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
17-May-2005


Page: 1 2

Related biology news :

1. Protein chatter linked to cancer activation
2. Coming soon -- Protein synthesis without amino acids?
3. Protein pulling -- Learning how proteins fold by pulling them apart
4. Protein interactions targets for Huntington disease therapy
5. Protein enables discovery of quantum effect in photosynthesis
6. Protein found that slows hepatitis C growth in liver cells
7. Protein fragments sequenced in 68 million-year-old Tyrannosaurus rex
8. Protein averts cell suicide but might contribute to cancer
9. Protein structures for the entire yeast proteome
10. Protein overexpression at heart of heart failure
11. Protein sciences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation of ... assays (LBA) have dominated this area. However, the use of mass spectrometry in this ... now necessitates the question “How do you choose which approach to use (LBA or ...
(Date:6/19/2020)... ... ... The director of stem cell biotechnology company Asymmetrex , Dr. James ... industries have easier access to stem cell counting, they will soon make it a ... Day weekend in the U.S., Asymmetrex is offering free tissue stem cell counting at ...
(Date:6/13/2020)... ... June 11, 2020 , ... Bode ... expansion of its forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) ... genealogy and DNA analysis methods. The team has added experienced genealogists, each having ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today ... 22-24 during the American Association for Cancer Research Virtual meeting. One poster describes ... consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, developer of NEON® ... Solution, a highly accurate, contact tracing solution for identification of employees who may ... core disease control measure, is a key strategy for preventing further spread of ...
(Date:5/30/2020)... YORK (PRWEB) , ... May 29, 2020 , ... ... of Chief Medical Officer 360°, the first newsletter solely dedicated to the unique ... capture a wide range of perspectives on the responsibilities, problem-solving, best practices and ...
(Date:5/21/2020)... ... 2020 , ... Experienced periodontist in Eden Prairie, MN, Dr. Andres Sanchez, offers ... PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations to gently cut bone in the ... dental implants, especially when the implants need to be placed in a sensitive area ...
Breaking Biology Technology:
Cached News: